Wijdenes J - Search Results

1

Interleukin-6 antibodies in rheumatoid arthritis.

Wijdenes J, Racadot E, Wendling D. Wijdenes J, et al. J Interferon Res. 1994 Oct;14(5):297-8. doi: 10.1089/jir.1994.14.297. J Interferon Res. 1994. PMID: 7861036 Clinical Trial. No abstract available.

2

A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.

Wendling D, Racadot E, Wijdenes J, Sibilia J, Flipo RM, Cantagrel A, Miossec P, Eschard JP, Macro M, Bertin P, Lioté F, Debiais F, Juvin R, Le Goff P, Masson C. Wendling D, et al. Among authors: wijdenes j. J Rheumatol. 1998 Aug;25(8):1457-61. J Rheumatol. 1998. PMID: 9712083 Clinical Trial.

3

Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience.

Herve P, Racadot E, Wendling D, Rumbach L, Tiberghien P, Cahn JY, Flesch M, Wijdenes J. Herve P, et al. Among authors: wijdenes j. Immunol Rev. 1992 Oct;129:31-55. doi: 10.1111/j.1600-065x.1992.tb01418.x. Immunol Rev. 1992. PMID: 1464420 Review. No abstract available.

4

Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone.

Wendling D, Racadot E, Morel-Fourrier B, Wijdenes J. Wendling D, et al. Among authors: wijdenes j. Clin Rheumatol. 1992 Dec;11(4):542-7. doi: 10.1007/BF02283116. Clin Rheumatol. 1992. PMID: 1486748

5

Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.

Wendling D, Racadot E, Wijdenes J. Wendling D, et al. Among authors: wijdenes j. J Rheumatol. 1993 Feb;20(2):259-62. J Rheumatol. 1993. PMID: 8474061 Clinical Trial.

6

Clinical and immunological follow-up of patients with AIDS-associated Kaposi's sarcoma treated with an anti-IL-6 monoclonal antibody.

Racadot E, Audhuy B, Duvernoy H, Thyss A, Lang JM, Wijdenes J, Hervé P. Racadot E, et al. Among authors: wijdenes j. Cytokines Mol Ther. 1995 Jun;1(2):133-8. Cytokines Mol Ther. 1995. PMID: 9384670 Clinical Trial.

7

Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock.

Boillot A, Capellier G, Racadot E, Wijdenes J, Herve P, Barale F. Boillot A, et al. Among authors: wijdenes j. Clin Intensive Care. 1995;6(2):52-6. Clin Intensive Care. 1995. PMID: 10150799 Clinical Trial.

8

Immunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5).

Racadot E, Wijdenes J, Wendling D. Racadot E, et al. Among authors: wijdenes j. Clin Exp Rheumatol. 1992 Jul-Aug;10(4):365-74. Clin Exp Rheumatol. 1992. PMID: 1356679

9

Monoclonal antibodies in human organ transplantation and auto-immune diseases.

Wijdenes J, Roy C, Morel-Fourrier B, Racadot E. Wijdenes J, et al. Therapie. 1992 Jul-Aug;47(4):283-7. Therapie. 1992. PMID: 1494788 Review.

10

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

Hervé P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, Plouvier E, Stephan JL, Bourdeau H, Holler E, et al. Hervé P, et al. Among authors: wijdenes j. Blood. 1992 Jun 15;79(12):3362-8. Blood. 1992. PMID: 1596576 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters